We found that low expression of PCK2 in HCC led to increased infiltration of endothelial cells and hematopoietic stem cells, which greatly increased the overall survival of patients, while low expression of PCK2 in HCC led to increased infiltration of MDSC, which greatly reduced the overall survival of HCC patients. This evidence concerns the gene PCK2 and hepatocellular carcinoma.